GCG and Alzheimer disease: The neuroprotective potential of GLP-1 has been established in models of neurodegenerative disorders, including Parkinson’s disease and Alzheimer’s disease (AD), with evidence suggesting it can modify disease progression and ameliorate pathology [29–32].